Vertical Transmission of HIV–An Update
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
One of the greatest successes in AIDS research to date has by far been the discovery of successful interventions that interrupt the transmission of HIV from mother to child. It is however important to note that these successes have occurred largely in countries with great resources and the least burden of perinatal transmission of HIV. In the developing world wherein currently 95% of vertical transmission of HIV occurs, it is highly condemnable that still every minute an infected infant is said to be born in spite of the fact that vertical transmission is largely preventable, mainly because translating knowledge into practice is not always possible or feasible; This has led to a continuous growing numbers of children with HIV, thereby making pediatric HIV a looming problem rapidly draining the already burdened health care system of these countries. It is the need of the hour to appropriately address the challenges to achieve zero percent transmission of HIV from an infected mother to her child thereby giving a hope for an AIDS-free new generation worldwide.
- UNAIDS. AIDS epidemic update. December 2007. Available at http://data.unaids.org/pub/EPISlides/2007/2007_epiupdate_en.pdf. Accessed on February 20th, 2010.
- UNAIDS. 2008 report on the global AIDS epidemic. Geneva; 2008. Available at http://www.unaids.org/en/KnowledgeCentre/HIVData/Global Report/2008. Accessed on February 20th, 2010.
- UNGASS Country Progress Report 2008: India. Available at http://www.india_2008_country_progress_report_en.pdf. Accessed on February 20th, 2010.
- De Cock KM, Fowler MG, Mercier E, de Vincenzi I, Saba J, Hoff E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. Jama. 2000;283(9):1175–82. CrossRef
- Five Phases of prevention of mother-to-child transmission. Available at http://www.dec.org/pdf docs/PNACN748.pdf. Accessed on February 20th, 2010.
- Towards universal access : scaling up priority HIV/AIDS interventions in the health sector: progress report 2008. Available at http://www.who.int/hivtowards_universal_access_report_2008.1.pdf.pdf. Accessed on February 20th, 2010.
- Perinatal HIV Guidelines Working Group. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. April 29, 2009; pp 1–90. Available at http://aidsinfo.nih.gov/ContentFiles/PerinatalGL.pdf. Accessed: February 20th, 2010.
- Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J AcquirImmune Defic Syndr. 2002;29:484–94.
- European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40:458–65. CrossRef
- Merchant RH, Lala MM. Prevention of mother-to-child transmission of HIV—an overview. Indian J Med Res. 2005;121:489–501.
- Arrive E, Newell M-L, Ekouevi DK, et al. Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis. Int J Epidemiol. 2007;36:1009–21. CrossRef
- Loubser S, Balfe P, Sherman G, Hammer S, Kuhn L, Morris L. Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission. Aids. 2006;20:995–1002. CrossRef
- Flys T, Nissley DV, Claasen CW, Jones D, Shi C, Guay LA, et al. Sensitive drug resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012. J Infect Dis. 2005;192:24–9. CrossRef
- Martinson NA, Ekouevi DK, Dabis F, Morris L, Lupodwana P, Tonwe-Gold B, et al. Transmission rates in consecutive pregnancies exposed to single-dose nevirapine in Soweto, South Africa and Abidjan, Cote d’Ivoire. J Acquir Immune Defic Syndr. 2007;45:206–9. CrossRef
- Michelle S, McConnell PB, Chineta E, et al. Effectiveness of repeat single-dose nevirapine for prevention of mother-to-child transmission of HIV-1 in repeat pregnancies in Uganda. J Acquir Immune Defic Syndr. 2007;46:291–6. CrossRef
- McConnell M, Bakaki P, Eure C, Mubiru M, Bagenda D, Downing R, et al. Effectiveness of repeat single-dose nevirapine for prevention of mother-to-child transmission of HIV-1 in repeat pregnancies in Uganda. J Acquir Immune Defic Syndr. 2007;46:291–6. CrossRef
- Jourdain G, Ngo-Giang-Huong N, Le Coeur S, Bowonwatanuwong C, Kantipong P, Leechanachai P, et al. Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy. N Engl J Med. 2004;351:229–40. CrossRef
- Lockman S, Shapiro RL, Smeaton LM, Wester C, Thior I, Stevens L, et al. Response to antiretroviral therapy after a single, peripartum dose of nevirapine. N Engl J Med. 2007;356:135–47. CrossRef
- Eshleman SH, Hoover DR, Chen S, Hudelson SE, Guay LA, Mwatha A, et al. Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP. J Infect Dis. 2005;192:30–6. CrossRef
- Eshleman SH, Becker-Pergola G, Deseyve M, Guay LA, Mracna M, Fleming T, et al. Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study). J Infect Dis. 2001;184:914–7. CrossRef
- Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, Berrebi A, Benifla JL, Burgard M, et al. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. Jama. 2001;285:2083–93. CrossRef
- Giuliano M, Palmisano L, Galluzzo CM, Amici R, Germinario E, Okong P, et al. Selection of resistance mutations in pregnant women receiving zidovudine and lamivudine to prevent HIV perinatal transmission. Aids. 2003;17:1570–2. CrossRef
- Bardeguez AD, Shapiro DE, Mofenson LM, Coombs R, Frenkel LM, Fowler MG, et al. Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival. J Acquir Immune Defic Syndr. 2003;32:170–81.
- Palumbo P, Holland B, Dobbs T, Pau CP, Luo CC, Abrams EJ, et al. Antiretroviral resistance mutations among pregnant human immunodeficiency virus type 1-infected women and their newborns in the United States: vertical transmission and clades. J Infect Dis. 2001;184:1120–6. CrossRef
- Spanish Perinatal Guidelines. Recomendaciones de la SPNS/GESIDA/SEGO/AEP Para el Seguimiento de la infeccion por el VIH conrelacion a la reproduccion, el embarazo y la prevencion de la transmision vertical. 2008. Available at http://www.msc.es/ciudadanos/enfLesiones/enfTransmisibles/sida/vigilancia/home.htm. Accessed on February 20th, 2010.
- Roberts SS, Martinez M, Covington DL, Rode RA, Pasley MV, Woodward WC. Lopinavir/ritonavir in pregnancy. J Acquir Immune Defic Syndr. 2009;51:456–61. CrossRef
- Revised WHO recommendations on the use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. 2009. Available at http://www.who.int/hiv/topics/mtct/. Accessed on February 20th, 2010.
- McIntyre JA, Hopley M, Moodley D, Eklund M, Gray GE, Hall DB, et al. Efficacy of short-course AZT Plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial. PLoS Medicine. 2009;6:10. CrossRef
- Chi BH, Sinkala M, Mbewe F, Cantrell RA, Kruse G, Chintu N, et al. Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial. Lancet. 2007;370:1698–705. CrossRef
- Rapid advice: use of antiretroviral drugs for treating pregnant women and preventing HIV Infection in infants. WHO 2009. Available at http://www.who.int/hiv/pub/mtct/rapid_advice_mtct.pdf. Accessed on February 20th, 2010.
- Merchant RH, Changedia S. Prevention of vertical transmission of human immunodeficiency virus. Indian Pediatr. 1997;34:475–80.
- Merchant RH, Damania K, Gilada IS, Bhagwat RV, Karkare JS, Oswal JS, et al. Strategy for preventing Vertical transmisssion of HIV: Bombay experience. Indian Pediatr. 2001;38:132–8.
- Lallemant M, Jourdain G, LeCouer S, et al. Single dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med. 2004;351:217–28. CrossRef
- Shapiro D, Tuomala R, Pollack H, et al. Mother-to child HIV transmission risk according to antiretroviral therapy, mode of delivery, and viral load in 2895 U.S. women (PACTG 367). 11th Conference on Retroviruses and Opportunistic Infections; February 8–11, 2004; San Francisco, CA. Abstract 99.
- BHIVA/CHIVA guidelines on the management of HIV infection in pregnant women. 2008. Available at http://www.bhiva.org/guidelines/2005/BHIVA-guidelines. Accessed on February 20th, 2010.
- Leroy V et al. Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa? AIDS. 2005;19(16):1865–75. CrossRef
- WHO. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants in resource-limited countries: towards universal access. Recommendations for a public health approach. Geneva: WHO; 2006. Available at http://www.who.int/hiv/pub/guidelines/WHOPMTCT.pdf. Accessed on February 20th, 2010.
- De Cock KM, Fowler MG, Mercier E, de Vincenzi I, Saba J, Hoff E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. Jama. 2000;283:1175–82. CrossRef
- Coutsoudis A, Dabis F, Fawzi W, Gaillard P, Haverkamp G, Harris DR, et al. Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis. 2004;189:2154–66. CrossRef
- Nduati R, John G, Mbori-Ngacha D, Richardson B, Overbaugh J, Mwatha A, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. Jama. 2000;283:1167–74. CrossRef
- Embree JE, Njenga S, Datta P, Nagelkerke NJ, Ndinya-Achola JO, Mohammed Z, et al. Risk factors for postnatal mother-child transmission of HIV-1. AIDS. 2000;14:2535–41. CrossRef
- Rapid advice: revised WHO principles and recommendations on infant feeding in the context of HIV. November 2009. Available at http://www.who.int/hiv/pub/mtct/rapid_advice_mtct_infantfeeding.pdf. Accessed on February 20th, 2010.
- Reeves JD, Doms RW. Human immunodeficiency virus type 2. J Gen Virol. 2002;83:1253–65.
- National AIDS Control Organization. Guidelines for HIV care & treatment infants & children. 2006. Available at http://www.nacoonline.org/NACO/. Accessed on February 21th, 2010.
- Vertical Transmission of HIV–An Update
The Indian Journal of Pediatrics
Volume 77, Issue 11 , pp 1270-1276
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Paediatric HIV
- Preventing mother-to-child transmission
- Vertical transmission
- Congenital infections
- Intrauterine infections
- HIV-2 in pregnancy and newborn
- Industry Sectors
- Author Affiliations
- 1. CCDT/MSF/Wadia Group of Hospitals, D-9, ParkBay, 295 CST Road, Kalina, Santacruz (East), Mumbai, 400098, Maharashtra, India
- 2. Bai Jerbai Hospital for Children, Mumbai, India
- 3. Nanavati Hospital & Asian Heart Institute, Mumbai, India